Related Experiment Video
Updated: Jul 13, 2026

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
Published on: March 30, 2014
Priority setting for high cost medications (HCMs) in public hospitals in Australia: a case study
Gisselle Gallego1, Susan Joyce Taylor, Jo-Anne Elizabeth Brien
1Centre for Health Economics Research and Evaluation (CHERE), University of Technology, Sydney, PO Box 123, Broadway, NSW 2007, Australia. gisselle.gallego@chere.uts.edu.au
Insights
Health care providers face funding challenges for high cost medicines (HCMs). Decisions on HCM access consider clinical need and treatment alternatives, not just cost and effectiveness, ensuring equitable resource allocation.
Area of Science:
- Health economics
- Pharmaceutical policy
- Medical ethics
Background:
- Healthcare providers face increasing financial pressures on health services.
- Allocating resources for high cost medicines (HCMs) presents significant challenges.
- Decision-making processes for HCM resource allocation are not well-documented.
Purpose of the Study:
- To describe the operations of the first High Cost Drug Sub-Committee (HCD-SC) in an Australian public hospital.
- To evaluate the HCD-SC's decision-making process using the "accountability for reasonableness" ethical framework.
Main Methods:
- Case study methodology.
- Description of the operational procedures of the HCD-SC.
- Evaluation of decision-making criteria using a recognized ethical framework.
Main Results:
- HCD-SC decisions incorporated factors beyond effectiveness and cost, including clinical need and availability of alternative treatments.
- Consistency in decision-making was a key consideration for HCD-SC members.
- The study provides insights into the practical application of ethical frameworks in resource allocation.
Conclusions:
- Hospital-based drug committees utilize multifaceted criteria for HCM access decisions.
- Ethical frameworks can guide resource allocation for expensive medications.
- Findings can inform strategies to optimize decision-making processes for HCM access.
Abstract:
Health care providers (HCPs) are increasingly aware of pressures on funding for health care services, including high cost medicines (HCMs). Allocating resources to innovative and expensive medications is particularly challenging and the decision-making processes and criteria used to allocate resources to HCMs have not been widely described in the literature. This case study aimed to describe the operations of the first reported High Cost Drug Sub-Committee (HCD-SC) in a public hospital in Australia. In addition the study also evaluated the decision-making process using Daniel and Sabin's ethical framework of "accountability for reasonableness". Some lessons emerged from the description of the operations of the HCD-SC. Decisions were not solely based on effectiveness and cost. Additional factors such as "clinical need" and the lack of an alternative treatment were involved in decisions about access to HCMs. Members of the HCD-SC also considered it was important to have consistency in the way decisions were being made. The findings from this study provide an evidence base for developing strategies to improve this hospital's decision-making process regarding access to HCMs.
Related Concept Videos
Methods Of Healthcare Delivery System
Managed Care System:
The managed care system is designed to control the cost while maintaining the quality of care. The patient's care from admission to discharge is planned by the primary care provider or the case manager, also known as the gatekeeper. In a managed care system, the number of care providers is limited...
Methods of Documentation VI: Case Management Model
For example, a patient with a chronic illness...
Primary Healthcare Services
In 1978, international leaders convened in Alma-Ata, Kazakhstan, for what would be a pivotal event in global health. The Alma-Ata Declaration was the first to call...
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Tertiary Healthcare System
Secondary Healthcare System
